Release
📈 Stocks
Sun Pharma Gains NCCN Category 2A Designation for UNLOXCYT in laCSCC
(just now)
Sun Pharma secures NCCN Category 2A Preferred Designation for UNLOXCYT in treating laCSCC, marking a key clinical milestone that strengthens the drug's…